Literature DB >> 16850502

Down-regulation of p21 (CDKN1A/CIP1) is inversely associated with microsatellite instability and CpG island methylator phenotype (CIMP) in colorectal cancer.

S Ogino1, T Kawasaki, G J Kirkner, A Ogawa, I Dorfman, M Loda, C S Fuchs.   

Abstract

p21 (CDKN1A/CIP1/WAF1), one of the cyclin-dependent kinase inhibitors, plays a key role in regulating the cell cycle and is transcriptionally regulated by p53. Down-regulation of p21 is caused by TP53 mutations in colorectal cancer. CpG island methylator phenotype (CIMP) appears to be a distinct subtype of colorectal cancer with concordant methylation of multiple gene promoters and is associated with a high degree of microsatellite instability (MSI-H) and BRAF mutations. However, no study to date has evaluated the relationship between p21 expression and CIMP in colorectal cancer. The purpose of this study was to examine the inter-relationships between p21, p53, CIMP, MSI and KRAS/BRAF status in colorectal cancer. We utilized 737 relatively unbiased samples of colorectal cancers from two large prospective cohort studies. Using quantitative real-time PCR (MethyLight), we measured DNA methylation in five CIMP-specific gene promoters [CACNA1G, CDKN2A (p16/INK4A), CRABP1, MLH1 and NEUROG1]. CIMP-high (>or=4/5 methylated promoters) was diagnosed in 118 (16%) of the 737 tumours. We also assessed expression of p21 and p53 by immunohistochemistry. Among the 737 tumours, 371 (50%) showed p21 loss. Both p21 loss and p53 positivity were inversely associated with CIMP-high, MSI-H and BRAF mutations. The associations of p21 with these molecular features were still present after tumours were stratified by p53 status. In contrast, the associations of p53 positivity with the molecular features were no longer present after tumours were stratified by p21 status. When CIMP-high and non-CIMP-high tumours were stratified by MSI or KRAS/BRAF status, CIMP-high and MSI-H (but not BRAF mutations) were still inversely associated with p21 loss. In conclusion, down-regulation of p21 is inversely correlated with CIMP-high and MSI-H in colorectal cancer, independent of TP53 and BRAF status.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16850502     DOI: 10.1002/path.2030

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  40 in total

Review 1.  Molecular pathological epidemiology of colorectal neoplasia: an emerging transdisciplinary and interdisciplinary field.

Authors:  Shuji Ogino; Andrew T Chan; Charles S Fuchs; Edward Giovannucci
Journal:  Gut       Date:  2010-10-29       Impact factor: 23.059

2.  CIMP and colon cancer gets more complicated.

Authors:  William M Grady
Journal:  Gut       Date:  2007-11       Impact factor: 23.059

Review 3.  Molecular classification and correlates in colorectal cancer.

Authors:  Shuji Ogino; Ajay Goel
Journal:  J Mol Diagn       Date:  2007-12-28       Impact factor: 5.568

4.  Cyclin D1 is frequently overexpressed in microsatellite unstable colorectal cancer, independent of CpG island methylator phenotype.

Authors:  K Nosho; T Kawasaki; A T Chan; M Ohnishi; Y Suemoto; G J Kirkner; C S Fuchs; S Ogino
Journal:  Histopathology       Date:  2008-11       Impact factor: 5.087

Review 5.  Prognostic significance of CDKN2A (p16) promoter methylation and loss of expression in 902 colorectal cancers: Cohort study and literature review.

Authors:  Kaori Shima; Katsuhiko Nosho; Yoshifumi Baba; Mami Cantor; Jeffrey A Meyerhardt; Edward L Giovannucci; Charles S Fuchs; Shuji Ogino
Journal:  Int J Cancer       Date:  2011-03-01       Impact factor: 7.396

Review 6.  Genetic variations in colorectal cancer risk and clinical outcome.

Authors:  Kejin Zhang; Jesse Civan; Sushmita Mukherjee; Fenil Patel; Hushan Yang
Journal:  World J Gastroenterol       Date:  2014-04-21       Impact factor: 5.742

7.  A cohort study of STMN1 expression in colorectal cancer: body mass index and prognosis.

Authors:  Shuji Ogino; Katsuhiko Nosho; Yoshifumi Baba; Shoko Kure; Kaori Shima; Natsumi Irahara; Saori Toyoda; Li Chen; Gregory J Kirkner; Brian M Wolpin; Andrew T Chan; Edward L Giovannucci; Charles S Fuchs
Journal:  Am J Gastroenterol       Date:  2009-06-09       Impact factor: 10.864

Review 8.  p21 in cancer: intricate networks and multiple activities.

Authors:  Tarek Abbas; Anindya Dutta
Journal:  Nat Rev Cancer       Date:  2009-06       Impact factor: 60.716

9.  Vitamin D receptor expression is associated with PIK3CA and KRAS mutations in colorectal cancer.

Authors:  Shoko Kure; Katsuhiko Nosho; Yoshifumi Baba; Natsumi Irahara; Kaori Shima; Kimmie Ng; Jeffrey A Meyerhardt; Edward L Giovannucci; Charles S Fuchs; Shuji Ogino
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-09-29       Impact factor: 4.254

10.  Epigenomic diversity of colorectal cancer indicated by LINE-1 methylation in a database of 869 tumors.

Authors:  Yoshifumi Baba; Curtis Huttenhower; Katsuhiko Nosho; Noriko Tanaka; Kaori Shima; Aditi Hazra; Eva S Schernhammer; David J Hunter; Edward L Giovannucci; Charles S Fuchs; Shuji Ogino
Journal:  Mol Cancer       Date:  2010-05-27       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.